Study of Ruxolitinib in Pancreatic Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Williams, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Hot Springs, Arkansas, United States
- Facility name not stated
Burbank, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Santa Monica, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Stamford, Connecticut, United States
- Facility name not stated
Boynton Beach, Florida, United States
- Facility name not stated
Fort Myers, Florida, United States
- Facility name not stated
St. Petersburg, Florida, United States
- Facility name not stated
Arlington Heights, Illinois, United States
- Facility name not stated
Elks Grove Village, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Sioux City, Iowa, United States
- Facility name not stated
Lexington, Kentucky, United States
- Facility name not stated
Louisville, Kentucky, United States
- Facility name not stated
Worcester, Massachusetts, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Grand Rapids, Michigan, United States
- Facility name not stated
Novi, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Voorhees Township, New Jersey, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Lake Success, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Hickory, North Carolina, United States
- Facility name not stated
Canton, Ohio, United States
- Facility name not stated
Dayton, Ohio, United States
- Facility name not stated
Tulsa, Oklahoma, United States
- Facility name not stated
Bend, Oregon, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Danville, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Knoxville, Tennessee, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Richmond, Virginia, United States
- Facility name not stated
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 30 Jun 2013
- Completion
- 30 Nov 2016
- Last update posted
- 12 Feb 2018
- Registered enrollment
- 136
- Registry id
- NCT01423604
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.